EH3

F:EH3 Germany Drug Manufacturers - General
Market Cap
$277.46 Million
€270.30 Million EUR
Market Cap Rank
#13929 Global
#1454 in Germany
Share Price
€13.00
Change (1 day)
+0.00%
52-Week Range
€11.20 - €14.00
All Time High
€14.00
Categories
Companies in Germany Drug Manufacturers - General
About

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. … Read more

EH3 (EH3) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.028x

Based on the latest financial reports, EH3 (EH3) has a cash flow conversion efficiency ratio of -0.028x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-12.70 Million) by net assets (€458.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

EH3 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how EH3's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

EH3 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EH3 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
WAAREE RENEWABLE TECHNOLOGIES LTD
NSE:WAAREERTL
 		N/A
Zhejiang Dilong New Material Co Ltd
SHE:002247
 		0.021x
Docebo Inc
NASDAQ:DCBO
 		0.118x
Villeroy und Boch AG Pfd.
LSE:0OPA
 		0.066x
Egis Technology
TWO:6462
 		-0.020x
Candel Therapeutics Inc
NASDAQ:CADL
 		-0.128x
PetroTal Corp
OTCQX:PTALF
 		0.086x
SYLVANIA PLAT. DL 001
F:31L
 		N/A

Annual Cash Flow Conversion Efficiency for EH3 (2021–2024)

The table below shows the annual cash flow conversion efficiency of EH3 from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €486.18 Million €-31.02 Million -0.064x -612.01%
2023-12-31 €552.10 Million €6.88 Million 0.012x +104.12%
2022-12-31 €595.33 Million €-180.09 Million -0.303x -203.29%
2021-12-31 €667.10 Million €-66.54 Million -0.100x --